Medical cannabis regulatory landscapes are beginning to open up in countries all over the world, providing opportunities for international partnerships in the cannabis market.

Even with the Canadian legal cannabis market still in its infancy, Canadian cannabis companies are already looking well beyond the True North to emerging medical cannabis markets and the recreational markets of tomorrow. Even before Canada became one of the first legal markets, Canadian companies were realizing the opportunity to become some of the first international cannabis players. While Canada offers the most established and developed legal cannabis landscape to date, markets in places like Latin America offer inexpensive production and highly promising markets in their own right.

For these companies looking to establish themselves in new and developing markets, partnerships with the players already entrenched in the country are key. Canadian companies with global aspirations have wasted no time forming international partnerships that will shape the worldwide cannabis industry and position them in promising markets.


What you need to know about Tesla's Battery Day

Expert Analysis of Tesla's Battery Day and the impact on Battery Metals Investing.

International partnerships in the cannabis market

Entering into a new national market is no easy task in any industry. For cannabis companies, navigating the regulatory landscapes makes the task even more complicated. Only in the last few years have governments the world over begun to take legal cannabis frameworks seriously, and regulatory schemes are still in development. The regulatory systems as they do exist can look very different from the ones Canadian companies are used to. This can make acquiring licenses and approvals difficult. In addition to regulatory challenges, any domestic market will have its own needs, tastes and cultural influences that do not necessarily line up with those of North American cannabis consumers. Long-term success in one of these markets will largely depend on a company’s ability to understand that market.

By partnering with a company already operating in the market of choice, Canadian cannabis companies effectively bypass many of these challenges. A pre-established domestic player will already have most if not all of the necessary licenses, as well as facilities that are up and running complete with a trained and experienced workforce. That company’s leadership will have experience with and contacts within the regulatory regime. Just as importantly, the company brass will be entrenched in the local culture and values with a finger on the pulse of the domestic market.

Cannabis in Colombia

Of the markets emerging today, Colombia is promising to become the king of the South American cannabis market. The country features a government that has been largely cooperative and willing to support legal cannabis. Colombia’s medical cannabis regulatory system is the most well-developed in Latin America. Under the leadership of President Manuel Santos, Colombia legalized medical cannabis in 2015 and by April 2017 the country had established its legal framework for commercial cultivation, production, extraction and distribution. The country has a population of 48.8 million and a domestic medical cannabis market of about 6 million potential patients.

For the North American companies partnering with Colombian entities, the production benefits of this market are clear. Colombia’s climate is ideally suited for outdoor growing of high-quality cannabis, saving producers the construction costs associated with on indoor facilities, necessary in colder climates like Canada, as well as the considerable electricity costs associated with indoor grow lights, ventilation systems, hydroponics and more. Resources needed for production are widely available at low cost. Colombia also features a large pool of knowledgeable and experienced low-cost labor. According to Canadian cannabis company Orion Nutraceuticals (CSE:ORI), high-quality cannabis can be produced for five cents per gram in Colombia, pennies on the dollar when compared to equivalent cannabis grown in North America.

The Colombian domestic market is only part of the story. The primary interest in Colombia by North American companies is in the country’s potential to become a cannabis supplier to the world. Colombia is conveniently situated close to North American markets, allowing for easy and cost-effective exportation. Colombian laws already allow for the export of low- and high-THC extracts. North American producers have realized the value in growing and extracting in Colombia and shipping that product back up north for huge margins.

A few noteworthy global partnerships

Orion Nutraceuticals is one of the Canadian companies who have entered the Colombian market via international partnership. Orion has set up a partnership with Colombian medical cannabis extract company FCM Global with an intent to obtain a 40 percent interest in the Colombian company. Among FCM’s assets is a 235,800-square-foot medical cannabis facility in the town of La Ceja, which is expected to have an annual production capacity of 50 tons of cannabis extract by 2020. FCM also owns a 450-hectare property in Natagaima, which includes 300 hectares of outdoor cannabis cultivation space with the remaining 150 hectares set aside for production and exportation infrastructure.


What you need to know about Tesla's Battery Day

Expert Analysis of Tesla's Battery Day and the impact on Battery Metals Investing.

“Our partnership with FCM Global is our most important one. The fact that we have this partnership with a company in Colombia that has licenses, boots on the ground and a facility, is growing cannabis and will continue to do so is immensely important for us going forward,” Orion Nutraceuticals CEO Jonathan Fiteni told INN.

In October 2018, Canopy Growth (TSX:WEED) launched a strategic partnership with Jamaican producer Grow House JA Ltd, adding Jamaica to a growing list of countries in which the cannabis giant has a presence including Germany, Australia, Chile, Spain and Denmark. Similarly, Canadian cannabis company Weekend Unlimited (CSE:YOLO) has entered into a binding letter of intent to acquire R&D Pharma, a Jamaican company with a Tier-3 cultivator’s license which allows for the cultivation of more than 5-acres of cannabis in Jamaica. MYM Nutraceuticals (CSE:MYM) has acquired a 49 percent stake in licensed Colombian cannabis producer ORGANICA.


The legal cannabis business is increasingly global. Opportunity abounds the world over in emerging markets that offer massive consumer bases, lower production costs, export opportunities and more. Canadian cannabis companies that have established themselves over the past several years now have a rare and valuable opportunity to enter these markets and the best way to do that will likely be through international partnerships with the local players.

This article was written according to INN editorial standards to educate investors.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less